Peter Silverstone
6Patents
1h-index
3Co-inventors
40Inventor score
Filing activity: Aug 7, 2007 → Nov 8, 2024
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7671094B2 | Bupropion hydrobromide and therapeutic applications | Human Necessities | 5 | Active |
| US11667607B1 | Crystalline forms of compositions comprising psilocin and psilocybin | Chemistry; Metallurgy | 1 | Active |
| US12351554B2 | Crystalline forms of compositions comprising psilocin and psilocybin | Chemistry; Metallurgy | 0 | Active |
| US12280068B1 | Uses of a co-crystal of psilocybin and psilocin | Human Necessities | 0 | Active |
| US12049447B2 | Crystalline forms of compositions comprising psilocin and psilocybin | Chemistry; Metallurgy | 0 | Active |
| US8354453B2 | Bupropion hydrobromide and therapeutic applications | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.